BES meeting 2023

14:30-15:45

Symposium 1 (sponsored by Lilly)
A New Horizon in The Management of Type 2 Diabetes.

• Welcome and introduction
  Christophe De Block (Belgium)

• Lecture 1: 
  Mechanism of action of next-generation incretins: unimolecular agonism GIP/GLP-1 and what’s next?
  Tim Heise (Germany)
• Lecture 2: 
  Striving for glycaemic control, is weight management the key to success? Surpassing standards of glucometabolic targets in T2D: achievable?
  
• André Scheen (Belgium)
• Panel discussion, audience questions & closing remarks
  Christophe De Block (chair, Belgium)
• 
  

16:00-17:15

Symposium 2 (sponsored by Rhythm Pharmaceuticals)
Hyperphagia and Genetic Obesity, a growing concern in daily practice. 

• Welcome and introduction 
  Roman Vangoitsenhoven (Belgium)
• Lecture 1
  Genetic impairments causing hyperfagia and early-onset, severe obesity - MC4R pathway diseases. 
  Metin Cetiner (Germany)
• Lecture 2
  Genetic testing – when to prescribe?
  Dr. Julie Harvengt (Belgium)
• Panel discussion, audience questions & closing remarks  
  Roman Vangoitsenhoven (chair, Belgium)

Coffee & visit of the exhibits

Welcome
B. Velkeniers (VUB), president

19:20

Evening symposium in collaboration with the Belgian Atherosclerosis Society (BAS) & Belgian Lipid Club (BLC)
Moderator: Fabian Demeure (CH UCL Namur)      

• Topic 1: Cardiovascular risk stratification: visionless or visionary? Ernst Rietzschel (UGhent)
• Topic 2: The future in lipid mangament: beyond LDL cholesterol
• • What about lp(a)?
    Ann Verhaegen (UZA)
  • What about remnant particles?
    Ann Mertens (UZLeuven)

20:00-22:00

Walking diner
Visit of the exhibits & poster viewing

What does BSED mean to the member of the Belgian Endocrine Society? 
Inge Van Boxelaer (BSED)

Invited lecture:
Introduced by O. Alexopoulou  (UCL)

Approach to the patient with pheochromocytoma
Michiel N. Kerstens (University of Groningen) 

9:30–10:30

Part 1: Clinical and translational studies
Chair: L. Crenier (ULB)

• The thiazide challenge test differentiates primary hyperparathyroidism from secondary hyperparathyroidism due to idiopathic hypercalciuria. 
  

  Ewout Verly (UGhent)
  
  

• Development of the KASAI score as a predictive tool for the uni- of bilateral form of primary hyperaldosteronism.
  

  Guillaume Pierman (UCL)
  
  
• In otherwise healthy young men, trabecular bone score (TBS) is significantly lower in case of insulin resistance: an analysis of the SIBLOS study.
  Steven Van Offel (UGhent)
  
  
• Hydrocortisone treatment increases cholesterol availability in prolonged septic mice: effect on adrenal and muscle functioning.
  Lauren De Bruyn (KUL)

10:30–11:00

Part 2: Clinical case reports
Chair: M. Bex (KUL)

• A non-controlled Cushing's disease treated with osilidrostat: a case report.
  Lore Depoorter  (UA)
  
  
• Unilateral mydriasis as a first presentation of pituitary macroadenoma.
  Tim Ailliet (St. Jan Brugge)

11:45–12:00

Selected Belgian Publication Award (sponsored by Sandoz)
Introduced by G. T'Sjoen (UGhent)

Leen Antonio et al. Age and Ageing 2022; 51 : 1-9

Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status. 
Presenting author: Leen Antonio (KUL)

12:00–12:30

Belgian Endocrine Society Lecture Award (sponsored by Novo)
Introduced by B. Velkeniers (VUB), President

The prismatic forms of diabetes in pediatrics:
natural evolution, strategies for β-cell replacement, and tolerance to physical activity. 
Award winner: Philippe Lysy (UCL) 

12:30-13:00

Invited lecture
Introduced by P. Petrossians (ULiège)

Hypocalcemia and genetics 

Bert Bravenboer (UBrussel)

Award ceremony of the young investigators